Shapefin

Translucent Secures $27 Million Series A Funding to Expand AI Platform for Healthcare Finance

Share It:

Translucent, an AI platform designed for healthcare finance, has announced the completion of a $27 million Series A funding round. The investment was led by GV (Google Ventures), with existing investors NEA, Virtue, and FPV Ventures also participating. This oversubscribed funding round follows the company’s $7 million seed round, which was announced in August 2025, underscoring the demand for real-time financial visibility within the healthcare industry.

Healthcare spending in the United States was projected to reach $5.6 trillion by the close of 2025, representing a 7.1% increase from the previous year, with indications of continued cost escalation into 2026. Despite this growth, the sector has faced challenges in achieving sustainable margins. The volume and complexity of data across various siloed areas, including labor, supplies, claims and contract economics, and equipment, have made real-time manual reconciliation impractical for healthcare finance teams. This often leads to managing financial operations retrospectively, a situation that contributed to 20 hospital bankruptcies and 23 hospital and emergency department closures last year. Currently, over 700 rural hospitals face the risk of closure.

Jack O’Hara, founder and CEO of Translucent, stated, “Healthcare organizations are in trouble, and the financial infrastructure that should help leaders respond is fundamentally broken. That’s why healthcare needs a true financial operating system built for this moment. We built Translucent to give hospitals and clinics what they desperately need: real-time clarity and control, so they can catch problems early enough to act and keep their doors open for the patients who need them.” O’Hara had previously observed the impact of opaque financial operations during his tenure at ChenMed and in rural health settings.

Translucent’s platform functions as an agentic AI solution for healthcare finance, integrating operational, clinical, and financial data into a unified view. It continuously monitors organizational signals to provide real-time financial insights and identify root causes as they emerge. The platform aims to replace fragmented tools, spreadsheets, and manual processes that have traditionally characterized healthcare financial operations, offering a consistent source of current data. This approach allows organizations to develop plans based on real-time information and take action proactively.

Healthcare organizations, including Northwestern Medicine, Duly Health and Care, Wray Hospital and Clinic, and Springfield Clinic, are among those utilizing Translucent to enhance their financial health. Even minor operational improvements, such as reducing manual reconciliation time in FP&A workflows or identifying multi-million-dollar provider productivity opportunities, can significantly impact financial performance.

John Orsini, Chief Financial Officer at Northwestern Medicine, commented, “Operating in an environment where every margin point matters, we see Translucent as an important tool that has the potential to help us improve the scale and visibility needed to better understand where revenue and operational opportunities exist. By bringing our clinical and financial teams together around the same real-time data, we look forward to improving alignment and supporting decisions that strengthen both our organization and the care we provide.”

John Everett, Chief Financial Officer at Wray Community District Hospital and Clinics, added,

Latest Posts